Enteral Nutrition & Amino Acid Absorption NCT02590120

Updated 05/31/2024

Clinical Trial Details — Status: Completed

Administrative data
NCT number	NCT02590120
Other study ID #	12.02.FR.NHS
Secondary ID
Status	Completed
Phase	N/A
First received
Last updated
Start date	February 2015
Est. completion date	December 2021

Study information
Verified date	March 2022
Source	Nestlé
Contact	n/a
Is FDA regulated	No
Health authority
Study type	Interventional

Clinical Trial Summary

The purpose of this study is to evaluate amino acid absorption with two different type of proteins.

Recruitment information / eligibility
Status	Completed
Enrollment	6
Est. completion date	December 2021
Est. primary completion date	December 2021
Accepts healthy volunteers	No
Gender	All
Age group	18 Years and older
Eligibility	Inclusion Criteria: - Patient with gastrointestinal disorder : citrulline plasma concentration < 20 µmol/L and/or xylose plasma concentration < 1,7 mmol/L - Patient under enteral nutrition at home - Patient already receiving 1 L by day Exclusion Criteria: - Obese patient BMI > 30 - Diabetes - Renal or liver failure - Glucocorticoids treatment

Study Design

Related Conditions & MeSH terms

Intervention

Dietary Supplement:
• Enteral nutrition

Locations
Country	Name	City	State
France	CHU de Lille	Lille

Sponsors *(1)*
Lead Sponsor	Collaborator
Nestlé

Country where clinical trial is conducted

France,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Amino acid absorption profile	Area under the curve of amino acid plasma concentration	48 hours
Secondary	Tolerance	Description and occurence of adverse events	48 hours
Secondary	Nutritional status	Retinol Binding Protein and Transthyretin dosage	48 hours
Secondary	Essentials amino acid absorption	Area under the curve of plasma concentration	48 hours
Secondary	Insulinemia evolution	Insulinemia dosage	48 hours
Secondary	Link between amino acid and insuline	Correlation coefficient	48 hours

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT05635747` - A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
	Recruiting	`NCT02247102` - Investigate the Breath Hydrogen Exhalation After a Test Meal Containing Isomaltulose or Sucrose in Infants	Phase 3
	Completed	`NCT04309214` - Market Research - Acceptability Study for New MCT Fat Products	N/A
	Recruiting	`NCT03530852` - A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB	N/A
	Completed	`NCT04309149` - Market Research - Acceptability Study for a Range of MCT Products	N/A
	Completed	`NCT00456729` - Malabsorption as a Cause of Iron Treatment Failure in Infants	N/A
	Completed	`NCT01862510` - Detection of Celiac Disease in Patients With Hypothyroidism	N/A
	Completed	`NCT02987569` - Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers	N/A
	Completed	`NCT03140371` - High Energy High Protein Peptide Feed Study	N/A
	Not yet recruiting	`NCT03897517` - Effect of Proprietary Botanical Blend on Glycemic Control and Post-prandial Carbohydrate Absorption	N/A
	Completed	`NCT02750787` - Use of a Peptide-based Formula in an Adult Population	N/A
	Completed	`NCT01900288` - Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research	N/A